-+ 0.00%
-+ 0.00%
-+ 0.00%

Insights Ahead: Spero Therapeutics's Quarterly Earnings

Benzinga·11/12/2025 16:02:48
Listen to the news

Spero Therapeutics (NASDAQ:SPRO) is set to give its latest quarterly earnings report on Thursday, 2025-11-13. Here's what investors need to know before the announcement.

Analysts estimate that Spero Therapeutics will report an earnings per share (EPS) of $-0.25.

The market awaits Spero Therapeutics's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Overview of Past Earnings

In the previous earnings release, the company beat EPS by $0.31, leading to a 18.01% drop in the share price the following trading session.

Here's a look at Spero Therapeutics's past performance and the resulting price change:

Quarter Q2 2025 Q1 2025 Q4 2024 Q3 2024
EPS Estimate -0.34 -0.55 -0.31 -0.36
EPS Actual -0.03 -0.25 -0.38 -0.32
Price Change % -18.00 -6.00 -11.00 -6.00

eps graph

Stock Performance

Shares of Spero Therapeutics were trading at $2.62 as of November 11. Over the last 52-week period, shares are up 112.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Spero Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.